Patient Preferences in Treatment of AMD: A DCE experiment

INGRESS is presenting a poster at ISPOR in Vienna! Age-related macular degeneration (AMD) is a major cause of visual impairment in the developed world, for which anti-vascular endothelial growth factor (VEGF) therapy is an effective treatment. However, recent evidence shows, that anti-VEGF treatment is not as effective in the everyday clinical setting as in clinical

Lees meer

Factors associated with the HrQoL of asthma patients

INGRESS is presenting a poster at ISPOR in Vienna! Asthma affects an estimated 300 million individuals worldwide. Provided that their asthma disease is properly treated, many patients can achieve a substantial improvement of their health-related quality of life (HrQoL). The aim of this study is to assess the real-life HrQoL of asthma patients in Germany

Lees meer

Designing and Conducting Medical Record Reviews in Oncology

INGRESS is presenting a poster at ISPOR in Vienna! A substantial part of real-world evidence data in oncology are generated based on medical record reviews (MRRs). Our study aims (1) to summarize methodology recommendations for oncology studies based on a MRR, (2) to describe the methodological trade-offs MRR studies in oncology might face, and (3)

Lees meer

Alan, welcome aboard!

We would like to wish to our newest consultant and friend, Alan, a very warm welcome! Alan holds a BA in Economics from Trinity College Dublin and and MSc in Health Economics from Erasmus University Rotterdam. He has one year of working experience in pan-European PRO studies. As a Junior Researcher, he supports health economics

Lees meer